Driven by Rising Awareness of Rapid Diagnosis amid Pandemic along with growing R&D investments by Market Players aided with Government support
The report titled “India Rapid IVD Kits Market Outlook to FY’2027F - Driven by Rising Awareness of Rapid Diagnosis amid Pandemic along with growing R&D investments by Market Players aided with Government support” by the publisher provides a comprehensive analysis of the potential of Rapid IVD Kits Industry in India. The report also covers overview and genesis of the industry, market size in terms of revenue generated and number of rapid kits supplied; Market Segmentation by type of test, by entity, by type of application, by mode of selling, by procurement, by type of end users, by region; challenges and bottlenecks, growth enablers and drivers; regulatory framework; competitive landscape including competition scenario, market shares of major operators on the basis of number of rapid kits supplied. The report concludes with future market projections of each product segmentation.
Detailed Analysis on the India Rapid IVD Kits Market:
India Rapid IVD Kits market is growing at a steady rate over the past few years, supported by increase in population in the country along with the awareness and acceptance of using rapid IVD Kit test for disease diagnosis owing to the Covid-19 pandemic crisis.
India Rapid IVD Kits market is highly fragmented market with SD Biosensor as the market leader owing to the high sales volume of rapid ivd test kits; followed J. Mitra & Co and Meril Diagnostic as the major local manufacturers in the market. The India Rapid IVD Kits Market also includes other major manufacturers such as Oscar Medicare, Abbott, Mankind Pharma, Angstrom Biotech, Mylab Discovery Solutions and more.
Improvement in healthcare infrastructure is also going to generate demand for such products in India. Going forward, rising demand for antibody tests, common/overlapping symptoms, impact of coronavirus, aging population, technological advances, increase in healthcare access, rising prevalence of chronic diseases and increasing adoption of self-testing kits over large number of diseases will drive the growth.
India Rapid IVD Kits Market Segmentation:
- By Type of Tests: Covid-19 Rapid Antigen Tests have dominated the market against Rapid IVD Tests owing to the shift in the focus from centralized testing to point-of-care testing and the emergence of the COVID-19 pandemic
- By Type of Entity: Majority of the entities in the India Rapid IVD Kits market are retailers followed by distributers and manufacturers.
Detailed Analysis on the India Rapid IVD Kits Market (Excluding Covid-19 Tests):
Emerging technological innovations in healthcare, such as bio-sensors, lab-on-a-chip, wearable devices, and POC diagnostics are increasingly becoming an important part of the healthcare landscape adding tailwinds to the rapid ivd kits market sector.
India Rapid IVD Kits industry (ex. Covid-19 test market) is expected to grow at a steady growth rate with a CAGR of 19.9% over the forecasted period FY’2022-FY’2027F. Factors, such as large outbreaks of bacterial and viral epidemics in India, increasing demand for point-of-care diagnostics, and rapidly evolving technology, are driving the growth of the molecular diagnostics segment.
India Rapid IVD Kits Market Segmentation
(Excluding Covid-19 Tests):
- By Type of Tests: In House Cassettes contributed majority percentage share in terms of total number of rapid ivd tests supplied in comparison to Dipstick tests in India.
- By Type of Application: Parasitological tests kits dominated the other tests by application in this segment due to the high parasitology disease prevalence across the country.
- By Parasitology Diseases Tests: Malaria rapid test kits contributed major chuck of share to this segment in terms of total number of parasitology disease test kits supplied.
- By Infectious Diseases Tests: HIV and HCV rapid test kits contributed major share to this segment in terms of total number of infectious disease test kits supplied.
- By Enteric Diseases Tests: Cholera and Typhoid rapid test kits contributed major share to this segment in terms of total number of enteric disease test kits supplied.
- By Fertility Marker Tests: Majority of the segment is dominated by Pregnancy-HCG Tests in comparison to LH and FSH rapid fertility tests.
- By Cardiac Marker Tests: Troponin 1 cardiac marker Test kits contributed majority percentage share in terms of total number of rapid tests supplied in comparison to Myoglobin cardiac marker tests owing to their high standards and sensitivity.
- By Procurement: Majority of the rapid ivd test kits are domestically manufactured whereas sourcing of raw materials is done via procurement from foreign countries to India.
- By Mode of Selling: Distributor Mediates mode of selling rapid ivd testing kits dominated direct sales-mode of selling as majority of end users are hospitals and other institutions.
- By Type of End Users: Public Health Corporations contributed majority of share in this segment in in comparison to other end users in terms of total number of rapid ivd test kits supplied.
- By Region: South Indian region dominated the rest in terms of total number of rapid ivd test kits supplied.
Detailed Analysis on the India Covid-19 Rapid Antigen Test Market:
The emergence of rapid POC technologies enabled facilities to optimize workflows and decreased labor requirements to process a higher sample load. For instance, due to the large-scale infection and strong transmissibility of COVID-19, high-throughput sequencing tools and automatic lab capacity became key factors of rapid diagnosis. India Rapid IVD Kits industry (ex. Covid-19 test market) is expected to grow at a CAGR of -32.1% over the forecasted period FY’2022-FY’2027F owing to the rising vaccination drives across the country, increasing testing capacity of diagnostic centers and surging awareness against the Covid-19 infection.
.
India Covid-19 Rapid Antigen Test Market Segmentation:
- By Type of Tests: In House Cassettes contributed majority percentage share in terms of total number of Covid-19 RAT tests sold in comparison to Dipstick tests in India.
- By Procurement: Majority of the Covid-19 RAT test kits are domestically manufactured whereas sourcing of raw materials is done via procurement from foreign countries to India.
- By Mode of Selling: Distributor Mediates mode of selling Covid-19 RAT test kits dominated direct sales-mode of selling as majority of end users are hospitals and other institutions.
- By Type of End Users: Public Health Corporations contributed majority of share in this segment in in comparison to other end users in terms of total number of Covid-19 RAT test kits sold.
- By Region: South Indian region dominated the rest in terms of total number of Covid-19 RAT test kits sold.
Key Segments Covered
India Rapid IVD Test Kits Market
By Type of Tests
- Rapid IVD Tests (Excluding Covid-19 Tests)
- Covid-19 Rapid Antigen Tests
By Type of Entity
- Manufactures
- Distributors
- Retailers
India Rapid IVD Test Kits Market on the basis of total number of tests supplied
By Type of Tests
- In House Cassettes
- Dipsticks
By Applications
- Parasitology Disease Tests
- Infectious Disease Tests
- Enteric Disease Tests
- Miscellaneous Tests
- Cardiac Markers
- Fertility Markers
By Parasitology Disease Tests
- Malaria Rapid Test
- Dengue Rapid Test
- Chikungunya Rapid Test
- Leishmaniasis (Kala azar) Rapid Test
By Infectious Disease Tests
- HIV Rapid Test
- HCV Rapid Test
- Syphilis Rapid Test
- HBsAg Rapid Test
- RIDT's Test (Influenza a/b)
By Enteric Disease Tests
- Cholera Rapid Test
- Typhoid Rapid Test
- H-Pylori Rapid Test
- ROTA Rapid Test
By Cardiac Marker Tests
- Troponin I Rapid Test
- Myoglobin Rapid Test
By Fertility Marker Tests
- Pregnancy (HCG) Rapid Test
- LH Rapid Test
- FSH Rapid Test
By Procurement
- Domestically Manufactured
- Imported
By Mode of Selling
- Distributor Mediates
- Direct Sales
By Type of End Users
- Public Health Corporations
- Pathology & Clinical Laboratories
- Private Hospitals
- Self-Testing Kits
By Region
- South India
- North India
- East India
- West India
India Covid-19 Rapid Antigen Test Market on the basis of total number of tests sold
By Type of Tests
- In House Cassettes
- Dipsticks
By Procurement
- Domestically Manufactured
- Imported
By Mode of Selling
- Distributor Mediates
- Direct Sales
By Type of End Users
- Public Health Corporations
- Pathology & Clinical Laboratories
- Private Hospitals
- Self-Testing Kits
By Region
- South India
- North India
- East India
- West India
Key Target Audience
- Rapid IVD Kits Manufacturers
- Rapid IVD Kits Distributors
- Rapid IVD Kits Retailers
- Public Health Corporations
- Pathology & Clinical Laboratories
- Private Hospitals
- Independent Reference Laboratories
- Diagnostic Laboratories
- Pathology Laboratories
- Clinical Laboratories
- Healthcare Institutions
- Research Institutes
- Market research and Consulting firms
Time Period Captured in the Report:
- Historical Period: FY’2017-FY’2022
- Forecast Period: FY’2022- FY’2027F
Companies Covered:
Rapid IVD Kits Manufacturers
- SD Biosensor Healthcare Pvt. Ltd.
- J. Mitra & Co. Pvt. Ltd.
- Meril Diagnostic Pvt. Ltd.
- Tulip Diagnostics Pvt. Ltd.
- Oscar Medicare
- Angstorm Biotech
- Ubio Biotechnology Systems
- Mylab Discovery Solutions Pvt. Ltd.
- Alpine Biomedicals Pvt. Ltd.
- Abbott
- Mankind Pharma
Key Topics Covered in the Report
- India Rapid IVD Kits Market Overview
- India Covid-19 Rapid Antigen Test Market Overview
- Supply Side Ecosystem of India Rapid IVD Kits Market
- Demand Side Ecosystem of India Rapid IVD Kits Market
- Snapshot of Rural Healthcare System in India
- Snapshot of Covid-19 in India
- Regulatory Framework for India Rapid IVD Kits Market
- Enablers and Growth Drivers in India Rapid IVD Kits Market
- Key Trends in India Rapid IVD Kits Market
- Major Challenges and Bottlenecks in India Rapid IVD Kits Market
- Porter’s Five Forces Analysis on India Rapid IVD Kits Market
- Offline and Online Tender Process for India Rapid IVD Kits Market
- End User Customer Preference in India Rapid IVD Kits Market
- Key Barriers faced by Companies to Access the India IVD Kits Market
- License Process for Importers and Manufacturers of Existing and New IVD Diagnostic Kits
- Competitive Landscape in India Rapid IVD Kits Market
- Detailed Analysis on India Rapid IVD Kits Market (Market Size, FY’2017-FY’2022; Market Segmentation; Future Market Size, FY’2027F)
- Detailed Analysis on India Rapid IVD Kits Market (Excluding Covid-19 Tests) (Market Size, FY’2017-FY’2022; Market Segmentation; Market Shares; Competition; Future Market Size, FY’2027F)
- Detailed Analysis on India Covid-19 Rapid Antigen Test Market (Market Size, FY’2017-FY’2022; Market Segmentation; Market Shares; Competition; Future Market Size, FY’2027F)
- Competitive Landscape in India Rapid IVD Kits Market
- Analyst Recommendations
Table of Contents
Executive Summary
The report titled “India Rapid IVD Kits Market Outlook to FY’2027F - Driven by Rising Awareness of Rapid Diagnosis amid Pandemic along with growing R&D investments by Market Players aided with Government support” by Ken Research provides a comprehensive analysis of the potential of Rapid IVD Kits Industry in India. The report also covers overview and genesis of the industry, market size in terms of revenue generated and number of rapid kits supplied; market segmentation by type of test, by entity, by type of application, by mode of selling, by procurement, by type of end users, by region; challenges and bottlenecks, growth enablers and drivers; regulatory framework; competitive landscape including competition scenario, market shares of major operators on the basis of number of rapid kits supplied. The report concludes with future market projections of each product segmentation.Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- SD Biosensor Healthcare Pvt. Ltd.
- J. Mitra & Co. Pvt. Ltd.
- Meril Diagnostic Pvt. Ltd.
- Tulip Diagnostics Pvt. Ltd.
- Oscar Medicare
- Angstorm Biotech
- Ubio Biotechnology Systems
- Mylab Discovery Solutions Pvt. Ltd.
- Alpine Biomedicals Pvt. Ltd.
- Abbott
- Mankind Pharma
